To prevent the body from metabolizing Drug G too quickly, a pharmaceutical company develops Substance Q to be taken concurrently with Drug G. If Substance Q binds to the enzyme catalyzing the metabolism of Drug G and alters its active site, what type of inhibition is occuring?
NON-COMPETITIVE INhibition